Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2020-12-22 2020-07-10
Drug Identification Number 00852384 00852384
Brand name TRANSDERM-NITRO 0.4 TRANSDERM-NITRO 0.4
Common or Proper name Transderm Nitro 0.4 Transderm Nitro 0.4
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients NITROGLYCERIN NITROGLYCERIN
Strength(s) 0.4MG 0.4MG
Dosage form(s) PATCH (EXTENDED RELEASE) PATCH (EXTENDED RELEASE)
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 30 30
ATC code C01DA C01DA
ATC description VASODILATORS USED IN CARDIAC DISEASES VASODILATORS USED IN CARDIAC DISEASES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-10-31 2020-10-31
Actual discontinuation date 2020-10-31
Remaining supply date 2020-10-31 2021-04-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021 The 0,6 mg will still be available until stock depletion or shelf life expiration (Aug 2021
Health Canada comments